Español
Português
Việt Nam
日本語
русский 
عربي 
Deutsch
한국어
Türkçe
Français
Italiano
Recently, Beijing Rosenbot Technology Co., Ltd. announced the completion of the B-round financing of over 100 million yuan. This round of financing was led by Beijing Zhongguancun Science City and Shenzhen Venture Capital, followed by Qingkong Merchants Fund and Shengjing Capital. Life Capital acted as exclusive financial advisor. This round of financing will be mainly used to accelerate new product development, clinical registration, production expansion and global marketing of surgical robots.
It is understood that Rosenbot was established in 2017. It is the product of the combination of medicine and engineering between Beihang University and Beijing Jishuitan Hospital, focusing on the original innovation of cutting-edge medical robot technology. The company is committed to creating a new generation of intelligent orthopedic surgery robot system with fracture reduction function, and is the first in the world to realize advanced technologies such as intraoperative real-time 3D navigation, assisted fracture reduction operation, and automatic surgical planning, and realizes from closed fracture reduction to minimally invasive fixation Intelligent surgical operation of the whole surgical process.
Closed reduction surgery for pelvic fractures faces two major problems: the difficulty of fully displaying the three-dimensional structure of the pelvis through intraoperative fluoroscopy images, and the need for precise position and posture adjustment under high loads in closed reduction. In response to this clinical demand, Rosenbert has developed a new generation of intelligent orthopedic surgery robot system with fracture reduction function, including real-time three-dimensional intraoperative navigation of fractures, computer-aided automatic planning, and robot autonomous reset operations. The hard parts are done by robots."
Wang Yu, the founder of Rosenbert, said: "We hope to use digital means to 'replicate' the rich experience of clinical experts to achieve personalized surgical planning. Relying on the R&D path of strong medical-industrial integration, Rosenbert aims to create a bottom-line with core competitiveness General software and hardware platform, future surgical robot will be a platform development path, Rosenbert will build a product innovation system driven by clinical needs, support us to cover more clinical needs in the future. The rapid development of robot technology is changing the medical field As an indispensable tool for minimally invasive surgery, robotic systems have the potential to reduce the total cost of social medical care and improve the accessibility of medical resources, and represent the future development direction of modern surgical technology."
The investment team of Tsing Kong Merchants Fund said: Medical-industrial intersection combines hard technologies such as AI, sensors, and robots with medical care. Through intelligence and digitization, machines can learn doctors' skills and experience, and present them stably, simplifying complex operations. , making major operations minimally invasive and popularizing medical resources; the intelligent pelvic reset robot developed by Rosenbert and Jishuitan Hospital combines advanced technologies such as preoperative automatic surgical planning, intraoperative 3D real-time visual navigation, and force-position collaborative precise operation. , broke through the limitations of doctors' "brain", "eyes" and "hands" in traditional surgery, and made pelvic closed reduction surgery more "precise", "minimally invasive" and "intelligent", even for a 92-year-old elderly in clinical trials Successful completion of closed minimally invasive pelvic reduction surgery; with the promotion of clinical and application of the product, it will help improve the level of fracture and trauma reduction treatment, replicate high-end surgical capabilities, expand the medical level of the hospital, and benefit the majority of patients.